Drug Profile
BW 192C86
Alternative Names: 192C86Latest Information Update: 02 Jul 2023
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Antiplatelets; Small molecules
- Mechanism of Action Platelet aggregation inhibitors; Prostaglandin agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Thrombosis
Most Recent Events
- 12 May 1995 Discontinued-I for Thrombosis in United Kingdom (Unknown route)